Hikma Pharmaceuticals (HIKL)

2,120.00p
   
  • Change Today:
      0.100p
  • 52 Week High: 2,348.00p
  • 52 Week Low: 1,769.00p
  • Currency: UK Pounds
  • Shares Issued: 199.39m
  • Volume: 145,282
  • Market Cap: £4,226.96m

Company Description

Drugs group Hikma, the first Jordanian company to list in London, makes branded prescription medicines and generic drugs.

IPO Details

Issue Date 01-Nov-2005 Prospectus n/a
Issue Price 290.00p Lead Broker Merrill Lynch
Market Cap £483.00m Contact Tel 020 7628 1000
Method Placing    
Sector Pharmaceuticals & Biotechnology    
Market Main    
Amount Raised £69.89m    

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

HIKL Market Data

Currency UK Pounds
Share Price 2,120.00p
Change Today 0.100p
% Change 0.47 %
52 Week High 2,348.00p
52 Week Low 1,769.00p
Volume 145,282
Shares Issued 199.39m
Market Cap £4,226.96m

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 2
Sell 0
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 06-Jun-2025

Time Volume / Share Price
16:29 112 @ 2,120.00p
16:29 15 @ 2,122.00p
16:29 184 @ 2,122.00p
16:27 161 @ 2,120.00p
16:27 164 @ 2,120.00p

HIKL Key Personnel

CEO Riad Mishlawi

Top of Page